NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email President Donald Trump’s Justice Department suffered two unqualified losses on Monday when a federal judge tossed out cases against former FBI Director James Comey and New York Attorney General Letitia James.Read More